Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cetirizine dihydrochloride (UCB P071) is an effective second-generation histamine H1 antagonist that is potent in the therapy of allergic rhinitis, confirmed urticaria, and pollen-induced asthma. Unlike other conventional antihistamines, it does not cause side effects of drowsiness or anticholinergic.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 36.00 | |
100 mg | In stock | $ 50.00 | |
200 mg | In stock | $ 72.00 | |
500 mg | In stock | $ 107.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Cetirizine dihydrochloride (UCB P071) is an effective second-generation histamine H1 antagonist that is potent in the therapy of allergic rhinitis, confirmed urticaria, and pollen-induced asthma. Unlike other conventional antihistamines, it does not cause side effects of drowsiness or anticholinergic. |
Synonyms | P071, UCB P071, Cetirizine DiHCl |
Molecular Weight | 461.81 |
Formula | C21H27Cl3N2O3 |
CAS No. | 83881-52-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 46.2 mg/mL (100 mM)
DMSO: 46.2 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cetirizine dihydrochloride 83881-52-1 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor rhinitis P-071 Seasonal histamine UCB P-071 P 071 IL-8 P071 allergic IL-1β Inhibitor UCB P071 GM-CSF inhibit SAR UCB P 071 Cetirizine DiHCl Cetirizine Dihydrochloride Cetirizine inhibitor